Finkelstein thompson llp announces investigation of novamed inc.

Washington--(business wire)--finkelstein thompson llp is investigating potential claims on behalf of shareholders of novamed inc. (“novamed” or the “company”) (nasdaq:nova) arising out of its efforts to sell the company to surgery center holdings, inc., an affiliate of h.i.g. capital, llc. under the terms of the proposed transaction, novamed shareholders will receive $13.25 in cash for each share of novamed common stock they hold. the transaction is expected to close in the second quarter of 2011. the investigation is focused on the potential unfairness of the deal price to novamed shareholders, the process by which novamed’s directors considered the transaction, and potential conflicts of interests on the part of novamed board members. a novamed shareholder has already asked the ambulatory surgery center operator to reconsider the proposed transaction. noble equity capital management said that the proposed transaction “does not sufficiently reward shareholders for the full value of the company.” if you are interested in discussing your rights as a novamed shareholder, or have information relating to this investigation, please contact finkelstein thompson's washington, dc offices at (877) 337-1050 or by email at contact@finkelsteinthompson.com. finkelstein thompson llp has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers. to learn more about finkelstein thompson llp, please visit our web site at www.finkelsteinthompson.com. attorney advertising. prior results do not guarantee similar outcomes.
NOVA Ratings Summary
NOVA Quant Ranking